Latest Unjha Formulations stock price
Unjha Formulations P/E Ratio
UNJHAFOR • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.98
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
21.98
Current Price
₹20.00
EPS (TTM)
₹0.91
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
47.99
Sector Median
27.37
Sector Rank
#11 of 140
Sector Percentile
7.9%
Key P/E Ratio Insights for Unjha Formulations
- Trading at discount to sector average PE of 47.99
View the UNJHAFOR equity price for detailed stock performance.
Related Pages for Unjha Formulations
Additional stock information and data for UNJHAFOR
Sector P/E Ratio Comparison
Comparing Unjha Formulations with other companies in Healthcare sector
Sector Average
47.99
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |